NexMed Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • NexMed's estimated annual revenue is currently $11.3M per year.(i)
  • NexMed's estimated revenue per employee is $155,000

Employee Data

  • NexMed has 73 Employees.(i)
  • NexMed grew their employee count by -14% last year.

NexMed's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is NexMed?

NexMed, USA is a wholly owned subsidiary of Apricus Biosciences (NASDAQ:APRI). The Company has a proprietary drug delivery technology, NexACT, which has been used to develop an impressive drug product pipeline, ranging from the pre-clinical stage to the NDA stage.

keywords:N/A

N/A

Total Funding

73

Number of Employees

$11.3M

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$16.4M736%N/A
#2
$17.7M7355%N/A
#3
$19.1M734%N/A
#4
$17.7M733%N/A
#5
$5.7M73-21%$155.6M